VBI Vaccines Inc.

About VBI Vaccines Inc.

VBI Vaccines is a biopharmaceutical company driven by immunology, focused on the prevention and treatment of infectious diseases and cancer through the development of innovative vaccines and immunotherapeutics. Their mission is to address significant unmet public health and medical needs by leveraging the human immune system to fight diseases such as highly contagious infections and fast-growing cancers.

Products & Services

PreHevbrio:A hepatitis B vaccine (recombinant) designed for prevention, though currently under voluntary nationwide recall due to discontinuation of company operations.

Pipeline Candidates (Prophylactic and Therapeutic):A range of vaccine and immunotherapeutic candidates targeting infectious diseases and oncology, designed to prevent and treat diseases by harnessing the immune system.

Specialties

Immunology Vaccine Development Immunotherapeutics Infectious Disease Prevention and Treatment Oncology (Cancer Treatment) Virus-Like Particle Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 2000000 MR: - FA: $2 million FAN: 2000000	D: 2024-04-11 FD: 2024-04-11	1 investors
2	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 2000000 MR: - FA: 2 million FAN: 2000000	D: 2024-04-09 FD: 2024-04-09	1 investors
3	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 2500000 MR: - FA: approximately $2.5 million FAN: 2500000	D: 2023-07-21 FD: 2023-07-21	2 investors
4	RT: Public Offering T: - FT: Public Offering	A: 21000000 MR: - FA: $21 million FAN: 21000000	D: 2023-07-06 FD: 2023-07-06	2 investors

Registered Direct Offering Latest

2024-04-11

$2.0M

1 investor (Pro only)

Registered Direct Offering 2024-04-09

$2.0M

Underwritten Public Offering 2023-07-21

$2.5M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

Damian Braga

Director

E

Eddy A. Bresnitz

Accomplished Public Health Physician

M

Michael D. Decker

Adjunct Professor of Preventive Medicine

J

John D. Grabenstein

Global vaccinologist, pharmacist, epidemiologist, and public-health leader

P

Pierre Van Damme

Full Professor at the University of Antwerp, Faculty of Medicine and Health Sciences

A

Adam Finn

Professor of Paediatrics

View 29 more team members with Pro

Unlock Full Team Directory

Recent News

VBI Vaccines Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised